Explore more topics
News sentiment

Tarsus Pharmaceuticals, Inc. Common Stock (TARS) news sentiment

How positive or negative Tarsus Pharmaceuticals, Inc. Common Stock's news headlines have been since Nov 16, 2020, week by week, with the last 90 sessions day by day and each recent headline's tone and source.

As of 2026-10-29

Average tone, last 30 sessions
0From -100 (every headline negative) to +100 (every headline positive)
Headlines, last 30 sessions
7
Headlines, last 90 sessions
32
Change from the 90-session average
-8
Latest session
2026-10-29

Weekly headline tone since November 2020

Hover a week for its biggest stories; click to pin.

Tone8-week averageHeadlinesFiltered out (passing mentions)
Every week since Nov 16, 2020
TARS headline tone: Every week since Nov 16, 2020, 146 weeks from November 16, 2020 to October 12, 2026.-100-75-50-25+25+50+75+1000Headlines202120222023202420252026

Coverage of Tarsus Pharmaceuticals, Inc. Common Stock over the last 30 trading sessions is neutral (0) across 7 headlines, 16 points below its one-year average of +16. The most widely carried story in the week of Oct 12, 2026 was "Reviewing Tarsus Pharmaceuticals (NASDAQ:TARS) and Novo Nordisk A/S (NYSE:NVO)", carried by 1 outlet.

Each point is one week of headlines about Tarsus Pharmaceuticals, Inc. Common Stock: the share of positive minus negative headlines, from -100 to +100, with the 8-week average drawn through it and the number of headlines beneath. Since coverage began, 354 headlines average +24.

Jump to a section

Tone mix

TARS headlines by tone, last 52 weeks
positive
25%
neutral
67%
negative
8%

Week by week 52 weeks

Dec 23, 2024: 2 positive, 2 neutral, 0 negativeDec 30, 2024: 1 positive, 0 neutral, 0 negativeJan 13, 2025: 0 positive, 0 neutral, 1 negativeJan 20, 2025: 1 positive, 3 neutral, 0 negativeJan 27, 2025: 1 positive, 0 neutral, 0 negativeFeb 3, 2025: 0 positive, 4 neutral, 0 negativeFeb 10, 2025: 0 positive, 1 neutral, 0 negativeFeb 24, 2025: 1 positive, 2 neutral, 1 negativeMar 10, 2025: 0 positive, 3 neutral, 0 negativeMar 17, 2025: 0 positive, 5 neutral, 0 negativeMar 31, 2025: 1 positive, 4 neutral, 0 negativeMay 5, 2025: 2 positive, 2 neutral, 0 negativeMay 26, 2025: 0 positive, 2 neutral, 0 negativeJun 2, 2025: 0 positive, 1 neutral, 0 negativeJun 9, 2025: 1 positive, 1 neutral, 0 negativeJun 30, 2025: 0 positive, 0 neutral, 1 negativeAug 18, 2025: 1 positive, 0 neutral, 1 negativeSep 1, 2025: 1 positive, 0 neutral, 0 negativeNov 3, 2025: 0 positive, 3 neutral, 0 negativeNov 10, 2025: 1 positive, 0 neutral, 0 negativeNov 17, 2025: 1 positive, 0 neutral, 0 negativeNov 24, 2025: 0 positive, 1 neutral, 0 negativeDec 8, 2025: 1 positive, 4 neutral, 1 negativeDec 15, 2025: 0 positive, 1 neutral, 0 negativeDec 29, 2025: 0 positive, 1 neutral, 0 negativeFeb 2, 2026: 0 positive, 1 neutral, 0 negativeFeb 9, 2026: 0 positive, 1 neutral, 0 negativeFeb 16, 2026: 0 positive, 1 neutral, 0 negativeFeb 23, 2026: 2 positive, 2 neutral, 1 negativeMar 9, 2026: 1 positive, 1 neutral, 0 negativeMar 16, 2026: 1 positive, 12 neutral, 0 negativeMar 23, 2026: 2 positive, 5 neutral, 0 negativeApr 6, 2026: 1 positive, 0 neutral, 0 negativeApr 13, 2026: 0 positive, 1 neutral, 0 negativeMay 4, 2026: 2 positive, 2 neutral, 0 negativeMay 11, 2026: 0 positive, 1 neutral, 0 negativeMay 25, 2026: 1 positive, 1 neutral, 0 negativeJun 8, 2026: 0 positive, 1 neutral, 0 negativeJun 15, 2026: 1 positive, 0 neutral, 0 negativeJun 22, 2026: 0 positive, 3 neutral, 0 negativeJun 29, 2026: 0 positive, 0 neutral, 1 negativeJul 6, 2026: 3 positive, 0 neutral, 1 negativeJul 13, 2026: 1 positive, 1 neutral, 0 negativeJul 27, 2026: 0 positive, 3 neutral, 0 negativeAug 3, 2026: 2 positive, 2 neutral, 1 negativeAug 10, 2026: 0 positive, 4 neutral, 2 negativeAug 31, 2026: 0 positive, 1 neutral, 0 negativeSep 7, 2026: 2 positive, 1 neutral, 0 negativeSep 21, 2026: 0 positive, 2 neutral, 0 negativeSep 28, 2026: 0 positive, 1 neutral, 0 negativeOct 5, 2026: 0 positive, 2 neutral, 0 negativeOct 12, 2026: 0 positive, 1 neutral, 0 negative
Dec 23, 2024Oct 12, 2026

Share of Tarsus Pharmaceuticals, Inc. Common Stock's 135 headlines over the last 52 weeks by the model's call, and the same mix week by week.

Biggest swings in the last year

The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.

Daily headline tone, last 90 sessions

Hover a session for its totals; click to pin.

Session tone8-session averageHeadlines
Last 24 sessions with a headline
TARS average headline tone by session: Last 24 sessions with a headline, 24 sessions from July 2, 2026 to October 28, 2026.-100-75-50-25+25+50+75+1000HeadlinesJul 2026AugSepOct

Each point is the average score of the headlines about Tarsus Pharmaceuticals, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.

Tone by period

Show the table · 3 rows, 3 columns

Scroll sideways to compare all columns. Select a heading to sort.

Last 7 sessions10
Last 30 sessions70
Last 90 sessions32+8

Every headline in the period counts equally.

Headlines on Wednesday, October 28, 2026

1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.

Show the table · 1 row, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

Tarsus Pharmaceuticals Appoints Neera Clase as Chief Commercial Officerwww.manilatimes.net1Neutral

Headlines on Monday, October 12, 2026

1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.

Show the table · 1 row, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

Reviewing Tarsus Pharmaceuticals (NASDAQ:TARS) and Novo Nordisk A/S (NYSE:NVO)www.themarketsdaily.com1Neutral

Headlines on Tuesday, October 6, 2026

1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.

Show the table · 1 row, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

Astrazeneca (NYSE:AZN) and Tarsus Pharmaceuticals (NASDAQ:TARS) Financial Reviewwww.dailypolitical.com1Neutral

Headlines on Monday, October 5, 2026

1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.

Show the table · 1 row, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

Recent Analysts' Ratings Updates for Tarsus Pharmaceuticals (TARS)www.themarketsdaily.com1Neutral

Headlines on Wednesday, September 30, 2026

1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.

Show the table · 1 row, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

Contrasting Tarsus Pharmaceuticals (NASDAQ:TARS) & Astrazeneca (NYSE:AZN)www.themarketsdaily.com1Neutral

How the score works

A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.

  1. Which headlines count

    Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Tarsus Pharmaceuticals, Inc. Common Stock, not a passing mention.

  2. How each headline is scored

    The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).

  3. When a headline counts

    Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.

  4. Repeated stories

    When several outlets carry the same headline, it counts once per session.